Table 3 Description of studies included in the scoping review (N = 21)
Variable | Number of studies (%) |
|---|---|
Sub-Saharan African countries | |
Ethiopia | 1 (4.8%) |
Guinea | 5 (23.8%) |
Kenya | 2 (9.5%) |
Liberia | 9 (42.9%) |
Nigeria | 1 (4.8%) |
Sierra Leone | 6 (25.6%) |
South Africa | 1 (4.8%) |
Type of data collected | |
Quantitative | 16 (76.2%) |
Qualitative | 2 (9.6%) |
Mixed methods/multi-methods | 3 (14.3%) |
Type of study | |
Observational | 21 (100%) |
Year of publication | |
2015 | 6 (28.6%) |
2016 | 2 (9.5%) |
2017 | 5 (23.8%) |
2018 | 1 (4.8%) |
2019 | 2 (9.5%) |
2020 | 5 (23.8%) |
Pandemic | |
Ebola | 18 (85.7%) |
COVID-19 | 3 (14.3%) |
Sexual reproductive health outcomesa | |
Labor and delivery (L&D) | 13 (61.9%) |
Family planning (FP) | 8 (38.1%) |
Antenatal care (ANC) | 7 (33.3%) |
HIV | 6 (28.6%) |
Maternal mortality (MM) | 4 (19%) |
Condoms | 1 (4.8%) |
Adolescents and young people (AYP) | 1 (4.8%) |